Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose.

TitleDosimetry in radionuclide therapy: the clinical role of measuring radiation dose.
Publication TypeJournal Article
Year of Publication2022
AuthorsLawhn-Heath C, Hope TA, Martinez J, Fung EK, Shin J, Seo Y, Flavell RR
JournalLancet Oncol
Volume23
Issue2
Paginatione75-e87
Date Published2022 02
ISSN1474-5488
KeywordsHumans, Liver Neoplasms, Male, Neoplasms, Neuroblastoma, Prostatic Neoplasms, Radioisotopes, Radiotherapy Dosage, Thyroid Neoplasms
Abstract

Radionuclide therapy is a rapidly expanding oncological treatment method. Overwhelmingly, the application of radionuclide therapy in clinical practice relies on fixed or empirical dosing strategies. In principle, the application of dosimetry promises to improve patient outcomes by tailoring administered radionuclide therapy activities to each patient's unique tumour burden and tumour uptake. However, robust prospective data are scarce due to few prospective randomised clinical trials investigating the use of dosimetry in radionuclide therapy. In this Review, we describe the role of dosimetry as it has been applied historically and in modern clinical practice and its potential future applications. We further emphasise areas of future growth and a potential pathway to optimised personalised activity modulation of radionuclide therapy.

DOI10.1016/S1470-2045(21)00657-4
Alternate JournalLancet Oncol
PubMed ID35114134

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065